- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RADLogics™ Adds AI Applications Modified for COVID-19 to Nuance Marketplace
Software supports CT and X-ray chest imaging.
RADLogics™ announced this week it is bringing additional software to the Nuance AI Marketplace, adding its artificial intelligence (AI)-powered medical imaging applications designed for the detection and quantification of COVID-19 findings.
The Nuance AI Marketplace is the first and largest one-stop portal that provides access to a myriad of AI diagnostic models. With this move, radiologists in more than 7,000 healthcare facilities nationwide can access the software applications.
These new medical imaging applications join RADLogic’s other patient triage and disease extent measurement tools. According to a company statement, these solutions have the capability of processing 1 million CT scans and 10 million X-rays daily through the RADLogic cloud-based platform.
Based on company information, the AI-powered software includes algorithms that can detect abnormalities on chest CTs and X-rays, as well as trigger automatic triage alerts to ensure a radiologist sees critical findings quickly. The company has modified its algorithms to detect lung abnormalities in patients who might have COVID-19. The tools, company officials said, are designed to provide quantitative analysis of CTs and X-rays, as well as provide a score than can help track findings over time.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
